BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,904 | -79.1% | 9,337 | -81.3% | 0.00% | -87.5% |
| Q1 2023 | $2,242,617 | +141300.8% | 49,847 | +37.7% | 0.01% | +33.3% |
| Q4 2022 | $1,586 | -100.0% | 36,211 | -39.1% | 0.01% | -60.0% |
| Q3 2022 | $3,916,000 | -83.1% | 59,430 | -87.0% | 0.02% | -82.6% |
| Q2 2022 | $23,174,000 | +32.1% | 458,806 | +67.0% | 0.09% | +75.5% |
| Q1 2022 | $17,548,000 | +180.9% | 274,707 | +370.9% | 0.05% | +172.2% |
| Q4 2021 | $6,248,000 | -75.3% | 58,333 | -76.3% | 0.02% | -77.8% |
| Q3 2021 | $25,307,000 | +9.7% | 246,151 | -6.1% | 0.08% | +3.8% |
| Q2 2021 | $23,068,000 | +188.4% | 262,259 | +204.0% | 0.08% | +73.3% |
| Q3 2020 | $7,998,000 | +1325.7% | 86,281 | +798.9% | 0.04% | +1025.0% |
| Q1 2020 | $561,000 | +134.7% | 9,599 | +221.3% | 0.00% | +100.0% |
| Q4 2019 | $239,000 | -83.3% | 2,988 | -83.3% | 0.00% | -84.6% |
| Q1 2019 | $1,429,000 | – | 17,846 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |